Sanofi Consumer Healthcare India Ltd.
NSE: SANOFICONR
Prev Close
4423.7
Open Price
4488.8
Volume
16,725
Today Low / High
4396.4 / 4575
52 WK Low / High
3975 / 5894.5
Range
4,309 - 4,763
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 4536, with a change of 112.3 (2.5386%). The expected target range on the NSE is between 4,309 - 4,763. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
Sanofi Consumer Healthcare India Ltd. Graph
Sanofi Consumer Healthcare India Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Sanofi Consumer Healthcare India Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 4,536.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 4,536.00 | 4,581.36 | 4,123.22 - 5,039.50 |
| 4,626.72 | 3,701.38 - 5,552.06 | ||
| 4,672.08 | 3,270.46 - 6,073.70 | ||
| Bearish Scenario | 4,536.00 | 4,490.64 | 4,041.58 - 4,939.70 |
| 4,445.28 | 3,556.22 - 5,334.34 | ||
| 4,399.92 | 3,079.94 - 5,719.90 |
Overview of Sanofi Consumer Healthcare India Ltd.
ISIN
INE0UOS01011
Industry
Drug Manufacturers - General
Vol.Avg
26,943
Market Cap
101,942,745,221
Last Dividend
55
Official Website
IPO Date
2024-09-13
DCF Diff
2,928.13
DCF
1,498
Financial Ratios Every Investor Needs
Stock Dividend of SANOFICONR
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-04-17 | April 17, 25 | 55 | 55 | 2025-04-17 | 2025-06-04 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 878.40 Cr | 370.60 Cr | 507.80 Cr | 0.5781 | 0.00 Cr | 0.00 Cr | 297.30 Cr | 240.10 Cr | 104.27 | 309.00 Cr | 0.2733 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 375.20 Cr | 547.00 Cr | 163.00 Cr | 384.0000 Cr | 41.90 Cr | -333.30 Cr | 61.90 Cr | 35.10 Cr | 0.00 Cr | 0.00 Cr | 3.20 Cr | 128.4000 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 188.0000 Cr | -7.6000 Cr | -132.5000 Cr | 180.4000 Cr | 48.3000 Cr | 375.2000 Cr | -7.6000 Cr | 240.1000 Cr | 0.0000 Cr | -126.7000 Cr | -21.0000 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 251.00 Cr | 107.20 Cr | 143.80 Cr | 0.5729 | 86.40 Cr | 66.50 Cr | 28.87 | 89.80 Cr | 0.2649 |
| 2025-09-30 | 233.90 Cr | 61.80 Cr | 172.10 Cr | 0.7358 | 81.70 Cr | 62.90 Cr | 27.31 | 88.00 Cr | 0.2689 |
| 2025-06-30 | 220.90 Cr | 61.20 Cr | 159.70 Cr | 0.7230 | 67.20 Cr | 60.70 Cr | 26.36 | 82.40 Cr | 0.2748 |
| 2025-03-31 | 172.60 Cr | 38.80 Cr | 133.80 Cr | 0.7752 | 62.00 Cr | 50.00 Cr | 21.69 | 69.20 Cr | 0.2897 |
| 2024-12-31 | 180.70 Cr | 84.60 Cr | 96.10 Cr | 0.5318 | 61.20 Cr | 44.30 Cr | 0.00 | 64.30 Cr | 0.2452 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 375.20 Cr | 0.00 Cr | 375.20 Cr | 29.70 Cr | 61.90 Cr | 494.30 Cr | 35.10 Cr | 547.00 Cr | 163.00 Cr |
| 2025-06-30 | 216.40 Cr | 1.60 Cr | 218.00 Cr | 44.50 Cr | 78.00 Cr | 366.10 Cr | 40.60 Cr | 422.00 Cr | 165.00 Cr |
| 2024-12-31 | 326.90 Cr | 3.80 Cr | 326.90 Cr | 18.10 Cr | 40.90 Cr | 391.70 Cr | 27.90 Cr | 431.30 Cr | 158.30 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - General
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Cipla Limited | CIPLA | ₹1,333.50 | ₹1,077,175,532,780.00 | ₹1,049,578.00 |
| Abbott India Limited | ABBOTINDIA | ₹26,810.00 | ₹569,693,786,620.00 | ₹9,947.00 |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO | ₹2,487.00 | ₹421,312,806,558.00 | ₹60,117.00 |
| Gland Pharma Limited | GLAND | ₹1,688.20 | ₹278,141,793,309.00 | ₹64,054.00 |
| Pfizer Limited | PFIZER | ₹4,803.50 | ₹219,749,230,662.00 | ₹16,656.00 |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR | ₹4,536.00 | ₹104,466,901,392.00 | ₹16,725.00 |
| Sanofi India Limited | SANOFI | ₹3,667.10 | ₹84,455,593,936.00 | ₹23,422.00 |
| Marksans Pharma Limited | MARKSANS | ₹174.06 | ₹78,877,681,629.00 | ₹409,913.00 |
| SMS Pharmaceuticals Limited | SMSPHARMA | ₹420.30 | ₹39,361,935,600.00 | ₹1,366,966.00 |
| Senores Pharmaceuticals Ltd. | SENORES | ₹759.70 | ₹34,986,910,804.00 | ₹108,067.00 |
Key Executives
Gender: male
Year Born: 1978
Gender: male
Year Born:
Gender: male
Year Born:
FAQs about Sanofi Consumer Healthcare India Ltd.
The CEO is Himanshu Bakshi.
The current price is ₹4,426.40.
The range is ₹3975-5894.5.
The market capitalization is ₹10,194.27 crores.
The dividend yield is 1.24%.
The P/E ratio is 42.46.
The company operates in the Healthcare sector.
Overview of Sanofi Consumer Healthcare India Ltd. (ISIN: INE0UOS01011) is a leading Drug Manufacturers - General in India. With a market capitalization of ₹10,194.27 crores and an average daily volume of 26,943 shares, it operates in the Drug Manufacturers - General. The company last declared a dividend of ₹55.